10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $979,646 | -28.6% | 23,749 | -3.3% | 0.01% | -27.3% |
| Q2 2023 | $1,371,207 | +10.9% | 24,556 | +10.8% | 0.01% | 0.0% |
| Q1 2023 | $1,236,251 | +58.1% | 22,159 | +3.3% | 0.01% | +37.5% |
| Q4 2022 | $781,857 | +19.6% | 21,456 | -6.6% | 0.01% | +14.3% |
| Q3 2022 | $654,000 | -36.5% | 22,972 | +0.9% | 0.01% | -30.0% |
| Q2 2022 | $1,030,000 | -37.5% | 22,756 | +5.0% | 0.01% | -23.1% |
| Q1 2022 | $1,648,000 | -47.2% | 21,670 | +3.3% | 0.01% | -45.8% |
| Q4 2021 | $3,124,000 | +3.1% | 20,969 | +0.7% | 0.02% | -4.0% |
| Q3 2021 | $3,031,000 | -25.1% | 20,817 | +0.7% | 0.02% | -24.2% |
| Q2 2021 | $4,049,000 | +21.0% | 20,679 | +11.8% | 0.03% | +13.8% |
| Q1 2021 | $3,347,000 | +34.3% | 18,489 | +5.0% | 0.03% | +26.1% |
| Q4 2020 | $2,493,000 | – | 17,605 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |